INVO Bioscience (NASDAQ:INVO) Trading Down 3.9% – Here’s Why

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) dropped 3.9% during mid-day trading on Wednesday . The company traded as low as $0.78 and last traded at $0.78. Approximately 25,997 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.81.

INVO Bioscience Stock Performance

The firm’s 50 day moving average price is $0.85 and its 200 day moving average price is $0.83.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. purchased a new position in INVO Bioscience, Inc. (NASDAQ:INVO) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned about 2.64% of INVO Bioscience at the end of the most recent reporting period. Institutional investors and hedge funds own 12.02% of the company’s stock.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.